Literature DB >> 19417094

Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans.

Glen E Foster1, Julien V Brugniaux, Vincent Pialoux, Cailean T C Duggan, Patrick J Hanly, Sofia B Ahmed, Marc J Poulin.   

Abstract

Intermittent hypoxia (IH) is thought to be responsible for many of the long-term cardiovascular consequences associated with obstructive sleep apnoea (OSA). Experimental human models of IH can aid in investigating the pathophysiology of these cardiovascular complications. The purpose of this study was to determine the effects of IH on the cardiovascular and cerebrovascular response to acute hypoxia and hypercapnia in an experimental human model that simulates the hypoxaemia experienced by OSA patients. We exposed 10 healthy, male subjects to IH for 4 consecutive days. The IH profile involved 2 min of hypoxia (nadir = 45.0 mmHg) alternating with 2 min of normoxia (peak = 88.0 mmHg) for 6 h. The cerebral blood flow response and the pressor responses to hypoxia and hypercapnia were assessed after 2 days of sham exposure, after each day of IH, and 4 days following the discontinuation of IH. Nitric oxide derivatives were measured at baseline and following the last exposure to IH. After 4 days of IH, mean arterial pressure increased by 4 mmHg (P < 0.01), nitric oxide derivatives were reduced by 55% (P < 0.05), the pressor response to acute hypoxia increased (P < 0.01), and the cerebral vascular resistance response to hypoxia increased (P < 0.01). IH alters blood pressure and cerebrovascular regulation, which is likely to contribute to the pathogenesis of cardiovascular and cerebrovascular disease in patients with OSA.

Entities:  

Mesh:

Year:  2009        PMID: 19417094      PMCID: PMC2727037          DOI: 10.1113/jphysiol.2009.171553

Source DB:  PubMed          Journal:  J Physiol        ISSN: 0022-3751            Impact factor:   5.182


  56 in total

1.  Assessment of intracranial hemodynamics in sleep apnea syndrome.

Authors:  J Klingelhöfer; G Hajak; D Sander; M Schulz-Varszegi; E Rüther; B Conrad
Journal:  Stroke       Date:  1992-10       Impact factor: 7.914

Review 2.  Morphology, physiology, and molecular biology of renin secretion.

Authors:  E Hackenthal; M Paul; D Ganten; R Taugner
Journal:  Physiol Rev       Date:  1990-10       Impact factor: 37.312

3.  Repetitive, episodic hypoxia causes diurnal elevation of blood pressure in rats.

Authors:  E C Fletcher; J Lesske; W Qian; C C Miller; T Unger
Journal:  Hypertension       Date:  1992-06       Impact factor: 10.190

4.  Simple, accurate equations for human blood O2 dissociation computations.

Authors:  J W Severinghaus
Journal:  J Appl Physiol Respir Environ Exerc Physiol       Date:  1979-03

5.  Carotid chemoreceptors, systemic blood pressure, and chronic episodic hypoxia mimicking sleep apnea.

Authors:  E C Fletcher; J Lesske; R Behm; C C Miller; H Stauss; T Unger
Journal:  J Appl Physiol (1985)       Date:  1992-05

6.  Prostanoid synthesis in response to high CO2 in newborn pig brain microvascular endothelial cells.

Authors:  P Hsu; M Shibata; C W Leffler
Journal:  Am J Physiol       Date:  1993-05

7.  Sympathetic denervation blocks blood pressure elevation in episodic hypoxia.

Authors:  E C Fletcher; J Lesske; J Culman; C C Miller; T Unger
Journal:  Hypertension       Date:  1992-11       Impact factor: 10.190

8.  Inflammation-induced endothelial dysfunction involves reduced nitric oxide bioavailability and increased oxidant stress.

Authors:  Brian R Clapp; Aroon D Hingorani; Rajesh K Kharbanda; Vidya Mohamed-Ali; Jeffrey W Stephens; Patrick Vallance; Raymond J MacAllister
Journal:  Cardiovasc Res       Date:  2004-10-01       Impact factor: 10.787

9.  Association of sleep apnoea with myocardial infarction in men.

Authors:  J Hung; E G Whitford; R W Parsons; D R Hillman
Journal:  Lancet       Date:  1990-08-04       Impact factor: 79.321

Review 10.  Blood pressure, stroke, and coronary heart disease. Part 2, Short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context.

Authors:  R Collins; R Peto; S MacMahon; P Hebert; N H Fiebach; K A Eberlein; J Godwin; N Qizilbash; J O Taylor; C H Hennekens
Journal:  Lancet       Date:  1990-04-07       Impact factor: 79.321

View more
  27 in total

1.  Losartan abolishes oxidative stress induced by intermittent hypoxia in humans.

Authors:  Vincent Pialoux; Glen E Foster; Sofia B Ahmed; Andrew E Beaudin; Patrick J Hanly; Marc J Poulin
Journal:  J Physiol       Date:  2011-09-19       Impact factor: 5.182

2.  CrossTalk proposal: Most of the cardiovascular consequences of OSA are due to increased sympathetic activity.

Authors:  Malcolm Kohler; John R Stradling
Journal:  J Physiol       Date:  2012-06-15       Impact factor: 5.182

Review 3.  Mechanisms of vascular damage in obstructive sleep apnea.

Authors:  Malcolm Kohler; John R Stradling
Journal:  Nat Rev Cardiol       Date:  2010-12       Impact factor: 32.419

4.  Identification of long noncoding RNAs involved in adaptability to chronic hypoxic by whole transcriptome sequencing.

Authors:  Zengrong Zhang; Mohan Qiu; Huarui Du; Qingyun Li; Chunlin Yu; Wu Gan; Han Peng; Bo Xia; Xia Xiong; Xiaoyan Song; Li Yang; Chenming Hu; Jialei Chen; Chaowu Yang; Xiaosong Jiang
Journal:  3 Biotech       Date:  2020-05-27       Impact factor: 2.406

5.  Effect on Intermittent Hypoxia on Plasma Exosomal Micro RNA Signature and Endothelial Function in Healthy Adults.

Authors:  Abdelnaby Khalyfa; Chunling Zhang; Ahamed A Khalyfa; Glen E Foster; Andrew E Beaudin; Jorge Andrade; Patrick J Hanly; Marc J Poulin; David Gozal
Journal:  Sleep       Date:  2016-12-01       Impact factor: 5.849

6.  Broken sleep: a new chronic intermittent hypoxia model for obstructive sleep apnoea.

Authors:  H J C Ravensbergen; I S Sahota
Journal:  J Physiol       Date:  2009-11-15       Impact factor: 5.182

7.  Could Adjunctive Pharmacology Mitigate Cardiovascular Consequences of Obstructive Sleep Apnea?

Authors:  Najib T Ayas; Glen E Foster; Neomi Shah; John Floras; Ismail Laher
Journal:  Am J Respir Crit Care Med       Date:  2019-09-01       Impact factor: 21.405

8.  Prevalence of obstructive sleep apnea in patients with chronic wounds.

Authors:  Brian T Patt; David Jarjoura; Lynn Lambert; Sashwati Roy; Gayle Gordillo; Richard Schlanger; Chandan K Sen; Rami N Khayat
Journal:  J Clin Sleep Med       Date:  2010-12-15       Impact factor: 4.062

Review 9.  Chemoreflexes, sleep apnea, and sympathetic dysregulation.

Authors:  Meghna P Mansukhani; Tomas Kara; Sean M Caples; Virend K Somers
Journal:  Curr Hypertens Rep       Date:  2014-09       Impact factor: 5.369

Review 10.  Quintessential risk factors: their role in promoting cognitive dysfunction and Alzheimer's disease.

Authors:  Mak Adam Daulatzai
Journal:  Neurochem Res       Date:  2012-08-12       Impact factor: 3.996

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.